EndoGene.Bio
PrivateLast Round
Grant
Jun 15, 2026
Total Funding Raised
$1.95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EndoGene.Bio is a biotechnology company that is developing a precision medicine platform using menstrual blood to create non-invasive diagnostics and tools for patient stratification for uterine diseases like endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EndoGene.Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
EndoGene.Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 15, 2026 | ||||
| Seed | Feb 1, 2025 |
Key People
Founding team and executive leadership
EndoGene.Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genopole | Seed |
| Hello Tomorrow | Grant |
| Entrepreneurs First | Seed, Accelerator |
| Bpifrance | Seed |
| Frontline Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2026
$107K grant received from Hello Tomorrow.
- Jan 8, 2026
Monthly visitors grew 1014% MoM, from 81 to 902.
EndoGene.Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EndoGene.Bio's valuation, stock price, and market status.